Similar incidence of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy.

Juan MacíasPaz González-MorenoEsther Sánchez-GarcíaRamón Morillo-VerdugoJosé J Pérez-VenegasAna PinillaMªMar MachoMªVictoria MartínezAlejandro González-SernaAnaïs CormaLuis Miguel Real Juan Antonio Pineda

Published in: PloS one (2021)

The incidence and severity of COVID-19 among patients with autoimmune rheumatic diseases with and without hydroxychloroquine was not significantly different.

Keyphrases

coronavirus disease
risk factors
respiratory syndrome coronavirus
sars cov
multiple sclerosis
stem cells
drug induced
cell therapy